Literature DB >> 30242917

Association of vitiligo with hospitalization for mental health disorders in US adults.

K R Patel1, V Singam1, S Rastogi1, H H Lee1, N B Silverberg2, J I Silverberg1,3.   

Abstract

BACKGROUND: Vitiligo has a complex bidirectional relationship with mental health (MH) disturbances. However, little is known about the relationship between vitiligo and MH emergencies.
OBJECTIVE: To examine the associations of vitiligo and MH hospitalizations in the United States.
METHODS: Data from the 2002 to 2012 National Inpatient Sample were analysed, including a ~20% sample of all US hospitalizations (n = 87 053 155 children and adults). Prevalence of hospitalization for MH disorders, their length of stay (LOS) and cost of care were determined for those with vitiligo compared to those without vitiligo.
RESULTS: Hospitalization for MH disorders occurred more commonly in those with vitiligo compared to those without vitiligo (4.17% vs. 2.18%). In multivariable logistic regression models, vitiligo was associated with higher odds of admission for any MH disorder [adjusted odds ratio (95% confidence interval): 1.69 (1.61-1.78)], including 14 of 15 MH disorders examined. Associated MH disorders included anxiety, schizophrenia, depression, suicidal risk, personality disorder, ADD/ADHD and conduct disorder, substance use disorder, childhood and adolescent psychiatric illnesses, alcohol-related disorders, adjustment disorders, developmental disorders, impulse control disorders, history of mental health disorders and miscellaneous mental health disorders. Vitiligo patients hospitalized with any MH disorder had higher geometric-mean (95% confidence interval) cost of inpatient care [$10 992 ($10 477-$11 507) vs. $10 082 ($9728-$10 435)] and LOS [5.6 (5.3-5.8) vs. 4.8 (4.6-4.9); P < 0.0001] compared to those without vitiligo, with $10.5 million excess annual costs from hospitalization with MH disorders in persons with vitiligo.
CONCLUSIONS: Persons with vitiligo had increased hospitalization for multiple MH disorders, which were associated with a considerable cost burden.
© 2018 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2018        PMID: 30242917     DOI: 10.1111/jdv.15255

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Patients' Perception of Vitiligo Severity.

Authors:  Nanja van Geel; Charlotte Moock; Marloes Zuidgeest; Sanne Elisabeth Uitentuis; Albert Wolkerstorfer; Reinhart Speeckaert
Journal:  Acta Derm Venereol       Date:  2021-06-28       Impact factor: 3.875

Review 2.  Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.

Authors:  Matthew Moyle; Ferda Cevikbas; Jamie L Harden; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2019-04-15       Impact factor: 3.960

3.  RNA-seq Reveals Dysregulation of Novel Melanocyte Genes upon Oxidative Stress: Implications in Vitiligo Pathogenesis.

Authors:  Konduru Seetharama Sastry; Haroon Naeem; Younes Mokrab; Aouatef Ismail Chouchane
Journal:  Oxid Med Cell Longev       Date:  2019-12-04       Impact factor: 6.543

4.  Psychosocial Effects of Vitiligo: A Systematic Literature Review.

Authors:  Khaled Ezzedine; Viktoria Eleftheriadou; Heather Jones; Kristen Bibeau; Fiona I Kuo; Daniel Sturm; Amit G Pandya
Journal:  Am J Clin Dermatol       Date:  2021-09-23       Impact factor: 7.403

5.  Identification of the Role of Wnt/β-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo.

Authors:  Si-Jia Zhao; Hong Jia; Xiu-Lian Xu; Wen-Bo Bu; Qian Zhang; Xi Chen; Juan Ji; Jian-Fang Sun
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-09-01

6.  The Current Status of Antioxidants in the Treatment of Vitiligo in China.

Authors:  Ying Zhou; Manal Khan; Ling Jiang; Chuhan Fu; Yumeng Dong; Liping Luo; Haoran Guo; Lijuan Gao; Xinxin Lei; Li Zhang; Xing Yu; Li Lei; Jinhua Huang; Jing Chen; Qinghai Zeng
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

Review 7.  Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

Authors:  Yinghan Wang; Shuli Li; Chunying Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-20       Impact factor: 8.667

8.  Meta-Analytic Review of High Anxiety Comorbidity among Patients with Vitiligo.

Authors:  Jiani Liu; Rui Tang; Yangfan Xiao; Mei Luo; Yaqian Shi; Qiancheng Deng; Huiming Zhang; Zhoutong Zeng; Zixin Pi; Rong Xiao
Journal:  Biomed Res Int       Date:  2021-05-17       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.